Home - Products - Chromatin/Epigenetic - Bromodomain - BET-BAY 002

BET-BAY 002

CAS No. 1588521-78-1

BET-BAY 002 ( BET-BAY-002 )

Catalog No. M12268 CAS No. 1588521-78-1

BET-BAY 002 is a potent BET bromodomain inhibitor; shows efficacy in a multiple myeloma model.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	312	Get Quote
50MG	1341	Get Quote
100MG	1791	Get Quote
200MG	Get Quote	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

BET-BAY 002
Note

Research use only, not for human use.
Brief Description

BET-BAY 002 is a potent BET bromodomain inhibitor; shows efficacy in a multiple myeloma model.
Description

BET-BAY 002 is a potent BET bromodomain inhibitor; shows efficacy in a multiple myeloma model.
Synonyms

BET-BAY-002
Pathway

Chromatin/Epigenetic
Target

Bromodomain
Recptor

Bromodomain
Research Area

Cancer
Indication

——

Chemical Information

CAS Number

1588521-78-1
Formula Weight

403.86
Molecular Formula

C22H18ClN5O
Purity

>98% (HPLC)
Solubility

10 mM in DMSO
SMILES

CC1=NN=C2N1C3=CC=CC=C3C(=CC2CC4=NN=C(O4)C)C5=CC=C(C=C5)Cl
Chemical Name

4H-[1,2,4]Triazolo[4,3-a][1]benzazepine, 6-(4-chlorophenyl)-1-methyl-4-[(5-methyl-1,3,4-oxadiazol-2-yl)methyl]-, (4R)-

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

CPI-637

A potent and selective, cell-active CBP/EP300 bromodomain inhibitor with CBP BRET EC50 of 0.03 uM.
GNE-207

GNE-207 (GNE207) is a novel potent, selective, orally active CBP/p300 bromodomain with IC50 of 1.0 nM.
I-BET151

I-BET151 (GSK1210151A) is a potent, selective BET bromodomain inhibitor.

Sign In Join Free